BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35697078)

  • 1. PLIN2 promotes HCC cells proliferation by inhibiting the degradation of HIF1α.
    Liu W; Liu X; Liu Y; Ling T; Chen D; Otkur W; Zhao H; Ma M; Ma K; Dong B; Yang Z; Piao HL; Liang R; Dong C
    Exp Cell Res; 2022 Sep; 418(1):113244. PubMed ID: 35697078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
    Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
    Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plin2 inhibits autophagy via activating AKT/mTOR pathway in non-small cell lung cancer.
    Wang Y; Hu Y; Xu R; Jin X; Jiao W
    Exp Cell Res; 2024 Feb; 435(2):113955. PubMed ID: 38301990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
    Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
    Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.
    Abu-Remaileh M; Khalaileh A; Pikarsky E; Aqeilan RI
    Cell Death Dis; 2018 May; 9(5):511. PubMed ID: 29724996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.
    Schnabl B; Valletta D; Kirovski G; Hellerbrand C
    Exp Mol Pathol; 2011 Dec; 91(3):695-701. PubMed ID: 21840307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation.
    Toshima T; Shirabe K; Matsumoto Y; Yoshiya S; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    J Gastroenterol; 2014 May; 49(5):907-16. PubMed ID: 23702609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
    Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
    World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
    Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
    Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUT11 is a target gene of HIF1α that promotes the progression of hepatocellular carcinoma.
    Ruan W; Yang Y; Yu Q; Huang T; Wang Y; Hua L; Zeng Z; Pan R
    Cell Biol Int; 2021 Nov; 45(11):2275-2286. PubMed ID: 34288238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
    Ibrahim AA; Schmithals C; Kowarz E; Köberle V; Kakoschky B; Pleli T; Kollmar O; Nitsch S; Waidmann O; Finkelmeier F; Zeuzem S; Korf HW; Schmid T; Weigert A; Kronenberger B; Marschalek R; Piiper A
    Clin Cancer Res; 2017 Jul; 23(14):3896-3905. PubMed ID: 28167508
    [No Abstract]   [Full Text] [Related]  

  • 15. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
    Wu FQ; Fang T; Yu LX; Lv GS; Lv HW; Liang D; Li T; Wang CZ; Tan YX; Ding J; Chen Y; Tang L; Guo LN; Tang SH; Yang W; Wang HY
    J Hepatol; 2016 Aug; 65(2):314-24. PubMed ID: 27154061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.
    Liu XW; Cai TY; Zhu H; Cao J; Su Y; Hu YZ; He QJ; Yang B
    Autophagy; 2014 Jan; 10(1):111-22. PubMed ID: 24220190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
    Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
    Kim SM; Han JM; Le TT; Sohng JK; Jung HJ
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.